CCR5

CCR5 분자 정보

영어 이름C-C chemokine receptor type 5시판 약물 수1
임상 약물 수13표적 별명CCR-5,Chemokine (C-C Motif) Receptor 5 (Gene/Pseudogene),C-C Motif Chemokine Receptor 5 A159A,Chemokine Recptor CCR5 Delta32,C-C Chemokine Receptor Type 5,Chemokine Receptor CCR5,CD195 Antigen,C-C CKR-5,CCCKR5,IDDM22,CKR-5,CKR5,Receptors, CCR5,C-C Motif Chemokine Receptor 5,CD195,CHEMR13,CCR5,HIV-1 fusion coreceptor,C-C Motif Chemokine Receptor 5 (Gene/Pseudogene),Chemokine (C-C Motif) Receptor 5,CC-CKR-5,CMKBR5
최고 연구 개발 단계Approved
영어 이름C-C chemokine receptor type 5
표적 별명CCR-5,Chemokine (C-C Motif) Receptor 5 (Gene/Pseudogene),C-C Motif Chemokine Receptor 5 A159A,Chemokine Recptor CCR5 Delta32,C-C Chemokine Receptor Type 5,Chemokine Receptor CCR5,CD195 Antigen,C-C CKR-5,CCCKR5,IDDM22,CKR-5,CKR5,Receptors, CCR5,C-C Motif Chemokine Receptor 5,CD195,CHEMR13,CCR5,HIV-1 fusion coreceptor,C-C Motif Chemokine Receptor 5 (Gene/Pseudogene),Chemokine (C-C Motif) Receptor 5,CC-CKR-5,CMKBR5
시판 약물 수1
임상 약물 수13
최고 연구 개발 단계Approved

CCR5 제품 목록

  • 속성

    Protein (4)Cell (1)

  • 제품 라이브러리

    온라인 (5)

  • Human (4)Mouse (1)

  • 태그

    His Tag & Flag Tag (2)- (2)GFP Tag (1)

  • 마커

    Unconjugated (3)- (1)GFP Fusion (1)

CCR5분자 별명

CCR5,CMKBR5,CD195,CC-CKR-5,CHEMR13

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Cenicriviroc mesylateCCR5/CCR2 antagonist; TBR-652; CVC; TAK-652Phase 3 ClinicalTakeda Pharmaceutical Co Ltd, Tobira Therapeutics IncAIDS Dementia Complex; Cholangitis, Sclerosing; Cognition Disorders; Coronavirus Disease 2019 (COVID-19); Diabetes Mellitus, Type 2; Hepatic Insufficiency; HIV Infections; Liver Cirrhosis; Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity; Prediabetic State
상세
SB-728-TSB-728mR-T; SB-728-TPhase 2 ClinicalSangamo BiosciencesHIV Infections
상세
VicrivirocSCH-D; MK-4176; SCH-417; Sch-417690Phase 2 ClinicalMerck & Co IncAcquired Immunodeficiency Syndrome; Colorectal Neoplasms; HIV Infections
상세
LeronlimabPA-14; PRO-140; HuPRO-140Phase 2 ClinicalProgenics Pharmaceuticals IncColorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Graft vs Host Disease; HIV Infections; Metabolic Dysfunction-Associated Steatotic Liver Disease; Rectal Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
상세
BMS-813160BMS-813160Phase 2 ClinicalBristol-Myers Squibb CompanyAdenocarcinoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Diabetic Nephropathies; Hyperplasia; Pancreatic Neoplasms
상세
RAP-103RAP-160; RAP-701; RAP-164; RAP-310; RAP-163; RAP-103Phase 2 ClinicalRapid PharmaceuticalsAlzheimer Disease; Hepatitis B; Neuralgia; Ovarian Neoplasms; Prostatic Neoplasms; Psoriasis
상세
Cenicriviroc mesylate/TropifexorLJC-242Phase 2 ClinicalNovartis Pharma AgMetabolic Dysfunction-Associated Steatotic Liver Disease
상세
AGT 103-TAGT 103-TPhase 1 ClinicalAmerican Gene Technologies International IncHIV Infections
상세
ThioravirocPhase 1 ClinicalShanghai Institute Of Materia Medica, Chinese Academy Of SciencesAmyotrophic Lateral Sclerosis; HIV Infections; Multiple Sclerosis
상세
BMS-687681BMS-687681Phase 1 ClinicalBristol-Myers Squibb CompanyNeoplasms
상세
SB-728-HSCSB-728-HSC; SB-728-HSPC; SB-728mR-HSPCPhase 1 ClinicalSangamo BiosciencesHIV Infections
상세
vMIP (Guangzhou Hongrun Biotech)Phase 1 ClinicalGuangzhou Hongrun Biotechnology Co LtdPneumonia
상세
LF-0376LF-0376Phase 1 ClinicalWuxi Hillhouse biomedicine Technology Co LtdColorectal Neoplasms; Liver Neoplasms; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Pancreatic Neoplasms; Solid tumours
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
MaravirocMVC; UK-427857ApprovedViiv HealthcareCelsentri, SelzentryUnited StatesHIV InfectionsViiv Healthcare Co2007-08-06Acquired Immunodeficiency Syndrome; Acute Lung Injury; AIDS Dementia Complex; Arthritis, Rheumatoid; Cardiovascular Diseases; Cognition Disorders; Coronavirus Disease 2019 (COVID-19); HIV Infections; Hypertriglyceridemia; Inflammation; Ischemic Stroke; Kidney Diseases; Primary Graft Dysfunction; Rejection of lung transplantation; Sarcoma, Kaposi; Stroke
상세
  • 분자 정보
  • 제품 목록
  • 시판 약물 정보
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호